Low prognostic implication of fibroblast growth factor family activation in triple-negative breast cancer subsets.

Ann Surg Oncol 2014 May 3;21(5):1561-8. Epub 2014 Jan 3.

Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea,

Background: Despite a greater understanding of the molecular heterogeneity of breast cancer, current therapeutic strategies still cannot overcome the relatively poor prognosis of triple-negative breast cancer (TNBC). Deregulation of fibroblast growth factor (FGF) signaling has been found in breast cancer, and blocking this pathway has been suggested as a potential therapeutic target. We therefore evaluated the expression and copy number changes of FGF family members in TNBC.

Methods: We retrospectively evaluated 148 primary TNBC in 2009 for FGFR1, FGFR2, and FGF2 expression by immunohistochemistry. FGFR1 and FGFR2 gene copy numbers were analyzed by fluorescence in situ hybridization. The Cancer Genome Atlas (TCGA) data was used to study correlations between gene expression and amplification or methylation of FGFR1, FGFR2, and FGF2 in basal-like TNBC.

Results: FGFR1, FGFR2, and FGF2 expression were found in 16.2 % (24 of 148), 12.8 % (19 of 148), and 12.8 % (19 of 148) of TNBCs, respectively. FGFR1 gene amplification was observed in 4.1 % (6 of 145), and FGFR1 high polysomy was detected in 6.9 % (10 of 145) of the cases examined. FGFR2 gene amplification and high polysomy were identified in 4.7 % (6 of 129 cases) and 0.8 % (1 of 129 cases), respectively. FGF2 expression was found to be associated with basal-like TNBC. The expression of FGF family members and FGFR1 or FGFR2 gene amplification did not affect patient survival. TCGA data revealed that promoter methylation of the 3 genes was significantly associated with mRNA expression.

Conclusions: Even though the implications for patient outcomes are not significant, subsets of TNBCs harbor FGFR1 or FGFR2 gene amplification and FGFR1, FGFR2, or FGF2 protein overexpression.

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-013-3456-xDOI Listing
May 2014
7 Reads

Publication Analysis

Top Keywords

fgfr1 fgfr2
28
breast cancer
16
fgfr2 gene
16
fgfr2 fgf2
16
gene amplification
16
fgf2 expression
12
fgfr1
9
triple-negative breast
8
tcga data
8
148 128
8
high polysomy
8
129 cases
8
fgf family
8
128 148
8
fibroblast growth
8
fgfr2
8
growth factor
8
family members
8
gene
6
expression
6

References

(Supplied by CrossRef)

BD Lehmann et al.
J Clin Invest 2011

V Ossovskaya et al.
Genes Cancer 2011

N Turner et al.
Oncogene 2010

AN Brooks et al.
Clin Cancer Res 2012

I Ahmad et al.
Biochim Biophys Acta 2012

S Elbauomy Elsheikh et al.
Breast Cancer Res 2007

ME Hammond et al.
J Clin Oncol 2010

YW Koh et al.
Mod Pathol 2011

MH Jang et al.
Breast Cancer Res 2012

F Cappuzzo et al.
J Natl Cancer Inst 2005

PJ Stephens et al.
Nature 2012

Similar Publications